•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 

S05338 Summary:

BILL NOS05338A
 
SAME ASNo Same As
 
SPONSORDIAZ
 
COSPNSRPERKINS
 
MLTSPNSR
 
Add §278-a, Pub Health L
 
Enacts the pharmaceutical cost transparency act requiring prescription drug manufacturers to file a report disclosing certain financial information pertaining to prescription drugs which have a wholesale acquisition cost of $10,000 or more annually or per course of treatment.
Go to top